RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

Regulatory Focus™ > News Articles > In Focus: FDA Compliance and Enforcement

In Focus: FDA Compliance and Enforcement

Posted 01 July 2011 | By Richard Morroney, CQA, RAC

Compliance and enforcement issues are of serious concern to medical product companies. If everyone followed the rules, why would we need the US Food and Drug Administration (FDA) to enforce them? But what are the rules and how do they apply to my particular industry or business? Do we even need rules or need FDA? I think history has proven the answer to be yes in both cases.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe

Regulatory Focus™ is doing essential, non-biased journalism during this unprecedented time. We appreciate your support as we bring you the news and intelligence you need to make an impact on global healthcare.

Regulatory Focus™ provides the intelligence you need to impact global healthcare during this crisis. Thank you for your support.